Short answer
Nurix Therapeutics, Inc. (NRIX) filed an 8-K current report with the SEC on May 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 83,747,013 shares represented 80.98% voting power, establishing quorum for all proposals.
Nurix Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 83,747,013 shares represented 80.98% voting power, establishing quorum for all proposals
- Three Class III directors re-elected through 2029, preserving Board continuity
- PwC appointment ratified for fiscal year ending November 30, 2026, with 83,555,977 votes supporting
- Executive compensation approved advisory basis, with 72,458,920 votes for and 6,895,394 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nurix Therapeutics, Inc. 8-K filings
Get the next NRIX 8-K as it lands
Follow NRIX for push alerts, or ask the research agent what this filing means.